What is ITF Pharma?
ITF Pharma, operating under the umbrella of the established Italfarmaco SpA, is a private multinational pharmaceutical group founded in 1938 and headquartered in Milan, Italy. The company is dedicated to the research, development, and production of high-quality prescription and over-the-counter drugs. With a strong focus on innovative solutions for disease prevention, management, and cure, ITF Pharma places particular emphasis on addressing rare diseases. Their mission is to enhance healthcare accessibility and effectiveness through pioneering research and development in critical therapeutic areas, driven by a commitment to scientific advancement and patient well-being.
How much funding has ITF Pharma raised?
ITF Pharma has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for ITF Pharma?
The recent strategic investment signals a pivotal moment for ITF Pharma, likely enabling accelerated expansion of its research and development pipeline, particularly in its focus areas of rare diseases and innovative drug discovery. This capital infusion is expected to bolster clinical trial progress, enhance manufacturing capabilities, and potentially facilitate market penetration for its advanced therapeutic solutions. The company's trajectory suggests a continued emphasis on scientific rigor and strategic partnerships to solidify its position in the competitive pharmaceutical landscape.
See full ITF Pharma company page
